greeksoup/ stock research

Healthpeak Properties (DOC) FY2023 results: revenue $2.2 billion, up 5.8% on the year

Healthpeak Properties, Inc. (DOC) reported revenue of $2.2 billion for fiscal 2023, the year ended 31 December 2023, up 5.8% on the year before. Net income was $306 million, down 38.9%, and diluted earnings per share $0.56. The figures are the company's own, from the 10-K it filed with the SEC on 9 February 2024.

Revenue
$2.2 billion
+5.8% on the year
FY2016FY2023
Operating margin
10.2%
8.3% a year earlier
FY2016FY2023
Net income
$306 million
-38.9% on the year
FY2016FY2023
Diluted EPS
$0.56
-39.1% on the year
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue2,1812,0611,896+5.8%
Cost of revenue902863773+4.5%
Gross profit1,2791,1981,123+6.7%
Gross margin58.6%58.1%59.2%
Operating income222172157+29.0%
Operating margin10.2%8.3%8.3%
Interest expense200173158+15.8%
Pre-tax income315507128-37.9%
Income tax-9.6-4.4-3.3
Effective tax rate-3.1%-0.9%-2.5%
Net income306500506-38.9%
Net margin14.0%24.3%26.7%
Diluted EPS$0.56$0.92$0.93-39.1%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow956900795+6.2%
Capital expenditure775962760-19.5%
Free cash flow182-61.735.5
Free cash flow margin8.3%-3.0%1.9%
Cash from investing-577-876531
Cash from financing-337-117-1,289
Depreciation and amortisation750711684+5.5%
Share-based compensation14.526.518.2-45.3%
Buybacks6.567.812.8-90.4%
Dividends paid657648650+1.4%
Dividend per share$1.20$1.20$1.200.0%
Diluted shares, weighted547m539m539m+1.5%
Shares outstanding at period end547m547m539m+0.1%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity6,3506,6556,515-4.6%
Non-controlling interest526528543-0.4%
Redeemable equity48.810687.3-53.8%
Debt6,8766,4986,170+5.8%
Other liabilities1,8981,9851,941-4.4%
Total liabilities and equity15,69915,77115,258-0.5%
Goodwill18.018.018.00.0%
Intangible assets314418520-24.9%
Loans218375416-41.7%
Cash and equivalents11872.0158+63.3%
Other assets15,03114,88814,146+1.0%
Total assets15,69915,77115,258-0.5%

10-K for the year ended 31 December 2023, filed 9 February 2024: the filing.